ArticleFrontiers in pharmacology2022

Luteolin enhances erlotinib's cell proliferation inhibitory and apoptotic effects in glioblastoma cell lines.

Erika Powe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.